|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| OPERATING EXPENSES | ||||
| Research and development | ||||
| General and administrative | ||||
| OPERATING LOSS | ||||
| Finance income | ||||
| NET LOSS | ||||
| EFFECT OF WARRANTS MODIFICATION, see Note 6 | ||||
| TOTAL NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS | ||||
| BASIC NET LOSS PER COMMON SHARE OUTSTANDING, see Note 8 | ||||
| DILUTED NET LOSS PER COMMON SHARE OUTSTANDING, see Note 8 | ||||
| Basic weighted average number of common shares outstanding | ||||
| Diluted weighted average number of common shares outstanding |
Loading...
